The effect of androgenic hormones on the reduced nicotinamide adenine dinucleotide phosphate:delta-4-3-ketosteroid 5 alpha-oxidoreductase of rat ventral prostate.
D000311:Adrenal Glands / Q000502:physiology; D000315:Adrenalectomy; D000731:Androstanes / Q000494:pharmacology; D000735:Androstenedione / Q000494:pharmacology; D000738:Androsterone / Q000494:pharmacology; D000818:Animals; D002369:Castration; D013196:Dihydrotestosterone / Q000494:pharmacology; D004958:Estradiol / Q000494:pharmacology; D007016:Hypophysectomy; D007664:Ketosteroids / Q000494:pharmacology; D008297:Male; D009249:NADP; D009929:Organ Size; D010088:Oxidoreductases / Q000378:metabolism*; D010280:Parathyroid Glands / Q000502:physiology; D010902:Pituitary Gland / Q000502:physiology; D011278:Pregnanes / Q000494:pharmacology; D011374:Progesterone / Q000494:pharmacology; D011467:Prostate / Q000187:drug effects / Q000201:enzymology*; D051381:Rats; D013737:Testis / Q000502:physiology; D013739:Testosterone / Q000494:pharmacology*; D013974:Thyroxine / Q000097:blood; D013997:Time Factors; D014316:Tritium
D000731:Androstanes; D007664:Ketosteroids; D011278:Pregnanes; D013196:Dihydrotestosterone; D014316:Tritium; D013739:Testosterone; D000735:Androstenedione; D011374:Progesterone; D004958:Estradiol; D009249:NADP; D000738:Androsterone; D010088:Oxidoreductases; D013974:Thyroxine